Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
59.50
+0.02 (0.03%)
May 13, 2026, 12:37 PM EDT - Market open

KNSA Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
4,5783,1471,4341,2361,044813
Market Cap Growth
192.28%119.41%16.06%18.37%28.45%-32.56%
Enterprise Value
4,1382,7401,1991,040856.08633.31
Last Close Price
59.5041.2519.7817.5414.9811.77
PE Ratio
65.5355.00-32.9787.705.76-5.12
Forward PE
46.9327.3242.93---
PS Ratio
6.104.643.394.574.7421.09
PB Ratio
7.245.543.272.822.644.39
P/TBV Ratio
7.915.743.222.882.664.36
P/FCF Ratio
27.9923.0756.4493.83183.11-6.41
P/OCF Ratio
27.7222.8155.8492.92179.80-6.44
EV/Sales Ratio
5.494.042.833.853.8916.43
EV/EBITDA Ratio
43.6134.78-27.29-45.4870.31-4.10
EV/EBIT Ratio
44.4035.48-26.28-41.2687.60-4.04
EV/FCF Ratio
25.2020.0847.1778.92150.14-5.00
Debt / Equity Ratio
0.010.010.020.020.010.01
Debt / EBITDA Ratio
0.100.12-0.22-0.540.49-0.04
Debt / FCF Ratio
0.060.070.390.931.04-0.05
Net Debt / Equity Ratio
-0.76-0.71-0.53-0.44-0.47-0.95
Net Debt / EBITDA Ratio
-4.84-5.145.328.49-15.171.14
Net Debt / FCF Ratio
-2.79-2.97-9.20-14.74-32.391.39
Asset Turnover
0.951.010.760.550.640.13
Inventory Turnover
1.261.912.121.271.814.95
Quick Ratio
3.143.092.843.584.484.15
Current Ratio
3.793.793.304.345.164.38
Return on Equity (ROE)
12.45%11.73%-9.85%3.37%63.10%-63.55%
Return on Assets (ROA)
15.38%15.35%-6.64%-14.54%-41.30%-53.33%
Return on Invested Capital (ROIC)
53.13%42.12%-14.09%-28.79%-118.29%-4448.43%
Return on Capital Employed (ROCE)
14.42%13.98%-9.68%-5.76%3.25%-61.96%
Earnings Yield
1.59%1.82%-3.03%1.14%17.36%-19.54%
FCF Yield
3.57%4.33%1.77%1.07%0.55%-15.59%
Buyback Yield / Dilution
-11.98%-10.58%0.69%-2.13%-2.69%-10.89%
Total Shareholder Return
-11.98%-10.58%0.69%-2.13%-2.69%-10.89%
Updated Apr 28, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q